HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carsten Zwick Selected Research

Complementary DNA (cDNA)

10/2009Analysis of the antibody repertoire of patients with mantle cell lymphoma directed against mantle cell lymphoma-associated antigens.
7/2006Serological immune response to cancer testis antigens in patients with pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carsten Zwick Research Topics

Disease

6Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2014 - 10/2002
6B-Cell Lymphoma (Lymphoma, B Cell)
07/2014 - 09/2009
6Neoplasms (Cancer)
07/2013 - 05/2002
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2014 - 12/2007
5Lymphoma (Lymphomas)
01/2014 - 12/2007
4Testicular Neoplasms (Testicular Cancer)
07/2013 - 10/2002
2Pancreatic Neoplasms (Pancreatic Cancer)
12/2012 - 07/2006
1Multiple Myeloma
09/2015
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
09/2015
1Pathologic Complete Response
07/2014
1Central Nervous System Diseases (CNS Diseases)
07/2014
1Cardiotoxicity
01/2014
1Drug-Related Side Effects and Adverse Reactions
01/2014
1Aneuploidy (Aneuploid)
07/2013
1Adenocarcinoma
12/2012
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2009
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
09/2009
1Melanoma (Melanoma, Malignant)
07/2007
1Infections
07/2007
1Lymphatic Metastasis
07/2006
1Chronic Pancreatitis
07/2006
1Seminoma
05/2002

Drug/Important Bio-Agent (IBA)

8Rituximab (Mabthera)FDA Link
12/2014 - 09/2008
7Prednisone (Sone)FDA LinkGeneric
04/2014 - 12/2007
6Vincristine (Oncovin)FDA LinkGeneric
04/2014 - 12/2007
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2014 - 12/2007
6AntigensIBA
07/2013 - 05/2002
4VaccinesIBA
07/2013 - 10/2002
4Neoplasm Antigens (Tumor Antigens)IBA
12/2012 - 10/2002
4AntibodiesIBA
09/2009 - 05/2002
3Doxorubicin (Adriamycin)FDA LinkGeneric
04/2014 - 03/2010
3Immunoglobulin G (IgG)IBA
09/2009 - 10/2002
2Etoposide (VP 16)FDA LinkGeneric
01/2014 - 09/2008
2Complementary DNA (cDNA)IBA
10/2009 - 07/2006
2Peptides (Polypeptides)IBA
07/2007 - 10/2002
1ParaproteinsIBA
09/2015
1Methotrexate (Mexate)FDA LinkGeneric
07/2014
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2014
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
01/2014
1Daunorubicin (Cerubidine)FDA LinkGeneric
01/2014
14-demethoxyanthracyclineIBA
01/2014
1Telomerase (Telomerase Reverse Transcriptase)IBA
07/2013
1Codon (Codons)IBA
12/2012
1Cancer VaccinesIBA
12/2012
1Prednisolone (Predate)FDA LinkGeneric
04/2012
1SurvivinIBA
09/2009
1Protein Kinase C betaIBA
09/2009
1Mitoxantrone (Novantrone)FDA LinkGeneric
09/2008
1Proteins (Proteins, Gene)FDA Link
07/2007
1UbiquitinIBA
07/2007
1MART-1 AntigenIBA
07/2007
1HLA-A*02:01 antigenIBA
07/2007
1GemcitabineFDA Link
07/2006
1SCP 1IBA
07/2006
1TESIBA
05/2002

Therapy/Procedure

3Radiotherapy
07/2014 - 11/2013
2Drug Therapy (Chemotherapy)
09/2008 - 12/2007
1Therapeutics
09/2008
1Immunotherapy
07/2006